Visceral fat and insulin resistance - causative or correlative?

被引:314
作者
Frayn, KN [1 ]
机构
[1] Radcliffe Infirm, Oxford Lipid Metab Grp, Oxford OX2 6HE, England
关键词
visceral fat; insulin resistance; non-esterified fatty acids; subcutaneous abdominal fat;
D O I
10.1017/S0007114500000982
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
The association between abdominal fat accumulation and risk of chronic diseases, including type II diabetes and coronary heart disease, has long been recognized. Insulin resistance may be a key factor in this link. Many studies have pointed to an association between insulin resistance and intra-abdominal fat accumulation (visceral obesity). However there is no clear proof of a causal link between visceral fat accumulation and insulin resistance. In assessing the probability of a causal link, it is useful to consider potential mechanisms. One such potential causal link is the release of non-esterified fatty acids from visceral fat into the portal vein, so that they have direct effects on hepatic metabolism. Visceral fat has been shown in many studies to exhibit a high rate of lipolysis compared with subcutaneous fat depots. However, if the idea that visceral fat releases fatty acids into the portal vein at a high rate is examined critically, a number of difficulties appear. Not least of these is the fact that continued high rates of lipolysis should lead to the disappearance of the visceral fat depot, unless these high rates of fat mobilization are matched by high rates of fat deposition. There is far less evidence for high rates of fat deposition in visceral adipose tissue, and some contrary evidence. Evidence for high rates of visceral lipolysisin vivo from studies involving catheterization of the portal vein is not strong. If this potential link is discounted, then other reasons for the relationship between visceral fat and insulin resistance must be considered. One is that there is no direct causal link, but both co-correlate with some other variable. A possibility is that this other variable is subcutaneous abdominal fat, which usually outweighs intra-abdominal fat several-fold. Subcutaneous fat probably plays the major role in determining systemic plasma non-esterified fatty acid concentrations, which are relevant in determining insulin resistance. In conclusion, there is at present no proof of a causal link between visceral fat accumulation and insulin resistance, or the associated metabolic syndrome. The possibility of co-correlation with some other factor, such as subcutaneous abdominal fat accumulation, must not be forgotten.
引用
收藏
页码:S71 / S77
页数:7
相关论文
共 58 条
[31]   Depot-specific differences in adipose tissue gene expression in lean and obese subjects [J].
Lefebvre, AM ;
Laville, M ;
Vega, N ;
Riou, JP ;
van Gaal, L ;
Auwerx, J ;
Vidal, H .
DIABETES, 1998, 47 (01) :98-103
[32]   THE MORPHOLOGY AND METABOLISM OF INTRAABDOMINAL ADIPOSE-TISSUE IN MEN [J].
MARIN, P ;
ANDERSSON, B ;
OTTOSSON, M ;
OLBE, L ;
CHOWDHURY, B ;
KVIST, H ;
HOLM, G ;
SJOSTROM, L ;
BJORNTORP, P .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1992, 41 (11) :1242-1248
[33]   EFFECTS OF BODY-FAT DISTRIBUTION ON REGIONAL LIPOLYSIS IN OBESITY [J].
MARTIN, ML ;
JENSEN, MD .
JOURNAL OF CLINICAL INVESTIGATION, 1991, 88 (02) :609-613
[34]  
MASLOWSKA MH, 1993, J LIPID RES, V34, P219
[35]  
MAURIEGE P, 1995, J LIPID RES, V36, P672
[36]   HETEROGENEOUS DISTRIBUTION OF BETA-ADRENOCEPTOR AND ALPHA-2-ADRENOCEPTOR BINDING-SITES IN HUMAN FAT-CELLS FROM VARIOUS FAT DEPOSITS - FUNCTIONAL CONSEQUENCES [J].
MAURIEGE, P ;
GALITZKY, J ;
BERLAN, M ;
LAFONTAN, M .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1987, 17 (02) :156-165
[37]   Relationship of anterior and posterior subcutaneous abdominal fat to insulin sensitivity in nondiabetic men [J].
Misra, A ;
Garg, A ;
Abate, N ;
Peshock, RM ;
StrayGundersen, J ;
Grundy, SM .
OBESITY RESEARCH, 1997, 5 (02) :93-99
[38]   Adipose tissue as an endocrine and paracrine organ [J].
Mohamed-Ali, V ;
Pinkney, JH ;
Coppack, SW .
INTERNATIONAL JOURNAL OF OBESITY, 1998, 22 (12) :1145-1158
[39]   Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-α, in vivo [J].
Mohamed-Ali, V ;
Goodrick, S ;
Rawesh, A ;
Katz, DR ;
Miles, JM ;
Yudkin, JS ;
Klein, S ;
Coppack, SW .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (12) :4196-4200
[40]   Depot-related gene expression in human subcutaneous and omental adipocytes [J].
Montague, CT ;
Prins, JB ;
Sanders, L ;
Zhang, JL ;
Sewter, CP ;
Digby, J ;
Byrne, CD ;
O'Rahilly, S .
DIABETES, 1998, 47 (09) :1384-1391